• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Engitix signs drug discovery and licensing deal with Takeda pharmaceutical-technology
    August 27, 2020
    UK-based biotechnology firm Engitix has signed a licensing and collaboration agreement with Takeda Pharmaceutical for the discovery and development of new drugs to treat fibrotic liver diseases.
  • Takeda signs deal with UK biotech Engitix pharmatimes
    August 26, 2020
    Takeda has signed a licensing agreement with UK biotech Engitix to develop new therapies for advanced fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service